| Title |
Agranulocytosis associated with dipyrone (metamizol)
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, December 2004
|
| DOI | 10.1007/s00228-004-0836-y |
| Pubmed ID | |
| Authors |
Luisa Ibáñez, Xavier Vidal, Elena Ballarín, Joan-Ramon Laporte |
| Abstract |
Reported estimates of the risk of agranulocytosis associated with metamizol have varied by several orders of magnitude. We assessed this association in a large database for the surveillance of blood dyscrasias. |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 8 | 50% |
| Brazil | 1 | 6% |
| Grenada | 1 | 6% |
| Argentina | 1 | 6% |
| Unknown | 5 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 69% |
| Practitioners (doctors, other healthcare professionals) | 3 | 19% |
| Scientists | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 90 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 13% |
| Student > Master | 11 | 12% |
| Other | 8 | 9% |
| Student > Ph. D. Student | 8 | 9% |
| Student > Postgraduate | 7 | 8% |
| Other | 22 | 24% |
| Unknown | 24 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 48% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 9% |
| Agricultural and Biological Sciences | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Nursing and Health Professions | 2 | 2% |
| Other | 7 | 8% |
| Unknown | 26 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2022.
All research outputs
#1,378,718
of 25,770,491 outputs
Outputs from European Journal of Clinical Pharmacology
#67
of 2,777 outputs
Outputs of similar age
#2,749
of 153,266 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#1
of 3 outputs
Altmetric has tracked 25,770,491 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,777 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 153,266 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them